SeLux Diagnostics - Crunchbase Company Profile & Funding

Q: Who invested in SeLux Diagnostics?

SeLux Diagnostics has 7 investors including Sands Capital Ventures And Schooner Capital.

Q: When was the last funding round for SeLux Diagnostics?

SeLux Diagnostics closed its last funding round on obfuscated from a Series D round.

Q: How much funding has SeLux Diagnostics raised to date?

SeLux Diagnostics has raised obfuscated.

Overview

SeLux Diagnostics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About SeLux Diagnostics

CB Rank

32727

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Founded

obfuscation

Private

Series D

Charlestown, Massachusetts, United States

101-250

www.seluxdx.com

Biotechnology

Health Care

Health Diagnostics

Therapeutics

Funding Rounds

Series D

OBF

obfuscation

Grant

OBF

obfuscation

Debt Financing

OBF

obfuscation

Key People

Eric Stern: CTO & Co-Founder
John Wilson: Chief Commercial Officer

Details

Legal Name

Selux Diagnostics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Aleksandar Vacic, Eric Stern

About the Company

SeLux Diagnostics is a developer of the next-generation phenotyping platform that provides personalized antimicrobial therapies to patients. The company is revolutionizing patient care by expediting the selection of personalized antimicrobial therapy for all infectious disease patients. This advancement will save lives, reduce hospital stays, and

address the escalating antibiotic resistance epidemic by minimizing the overuse of broad-spectrum agents.

Phone Number

617-945-9383

Contact Email

info@seluxdx.com

Predictions & Insights

Growth Insight

See this Growth Insight

SeLux Diagnostics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Selux Next Generation Phenotyping (NGP) System

A rapid antibiotic susceptibility testing system using a proprietary 384-well panel to provide fast, accurate phenotypic antimicrobial susceptibility results.

Selux Inoculator

An automated pipetting instrument that prepares the 384-well AST panel by dispensing precise sample concentrations in complex patterns for susceptibility testing.

Research & Development

SeLux Diagnostics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D
obfuscated obfuscation	Series D - SeLux Diagnostics	4	obfuscated obfuscation	RA Capital Management	Series D

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Sands Capital Ventures	—	Series D - SeLux Diagnostics	—
Sands Capital Ventures	—	Series D - SeLux Diagnostics	—
Sands Capital Ventures	—	Series D - SeLux Diagnostics	—
Sands Capital Ventures	—	Series D - SeLux Diagnostics	—
Sands Capital Ventures	—	Series D - SeLux Diagnostics	—